Sagent Pharmaceuticals Launches Oxacillin for Injection
Sagent Pharmaceuticals announced the launch of Oxacillin for Injection, USP, in three latex-free, preservative-free vial presentations.
Oxacillin features the company's PreventIV Measures packaging and labeling designed to aid in the reduction of medication errors.
Oxacillin for Injection, USP is a semisynthetic penicillin indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.
For more information call (866) 625-1618 or visit www.sagentpharma.com.